Medical treatment of ectopic pregnancy with methotrexate has been shown to
be effective and safe in appropriate patients. When considering medical man
agement, the definitive diagnosis of an ectopic pregnancy and the assurance
that the patient is a candidate are of paramount concern. An understanding
of the mechansim of action and pharmacokinetics of methotrexate allows the
clinician to better inform patients, recognize and treat side effects, and
be cognizant when treatment is unseccessful. Two common protocols, the "mu
lti-dose" and the "single-dose" protocols, have excellent success rates; ho
wever, neither one of these is completely effective. The "multi-dose" proto
col appears to have a higher success rate than the "single-dose" protocol.